Last update 01 Nov 2024
UP-818-CC
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms + [3] |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization  Usun BioStartup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with UP-818-CC评价TISA-818含漱液经口腔黏膜局部给药在头颈部肿瘤患者中防治放射性口腔黏膜炎的安全性、耐受性、药代动力学及有效性的一项随机、多中心、剂量递增、疗程扩展的I/IIa期临床研究
[Translation] A randomized, multicenter, dose-escalation, treatment extension phase I/IIa clinical study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of TISA-818 oral rinse administered topically via the oral mucosa for the prevention and treatment of radiation oral mucositis in patients with head and neck cancer
评价TISA-818-Inj治疗急性呼吸窘迫综合征患者的安全性和初步有效性的随机、双盲、安慰剂对照的II期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase II clinical trial to evaluate the safety and preliminary efficacy of TISA-818-Inj in the treatment of patients with acute respiratory distress syndrome
一项在中国健康受试者中评价UP-818-CC注射液单剂及多剂静脉输注给药安全性、耐受性、药代动力学的单中心、随机、双盲、安慰剂对照的I期临床试验
[Translation] A single-center, randomized, double-blind, placebo-controlled Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of single and multiple intravenous infusions of UP-818-CC injection in healthy Chinese subjects
100 Clinical Results associated with UP-818-CC
Login to view more data
100 Translational Medicine associated with UP-818-CC
Login to view more data
100 Patents (Medical) associated with UP-818-CC
Login to view more data
100 Deals associated with UP-818-CC
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Respiratory Distress Syndrome, Acute | Phase 2 | CN | Usun BioStartup | 15 Nov 2023 |
| Respiratory Distress Syndrome, Acute | Phase 2 | CN | 15 Nov 2023 | |
| Respiratory Distress Syndrome, Adult | Phase 2 | CN | Usun BioStartup | 15 Nov 2023 |
| Respiratory Distress Syndrome, Adult | Phase 2 | CN | 15 Nov 2023 | |
| radiation oral mucositis | Phase 1 | CN | 05 Sep 2024 | |
| Acute Lung Injury | Phase 1 | CN | Usun BioStartup | 14 Feb 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free